
Castle Biosciences Inc
CSTLNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$21.99
Day High
$22.14
Day Low
$20.99
Prev. Close
$22.11
VolumeShares traded today.
332.18K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$639.36M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-49.08
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$44.28
52W LowLowest price over the past 52 weeks.
$14.59
50D MAAverage closing price over the last 50 trading days.
$23.08
200D MAAverage closing price over the last 200 trading days.
$28.74
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+2.6%1M
-13.0%6M
-47.2%YTD
-45.3%1Y
+32.0%About
DecisionDx-UM is a prognostic test that accurately determines the metastatic risk associated with ocular melanoma tumors of the eye. Ocular melanoma is a term commonly used to describe tumors of the uveal tract such as uveal melanoma, choroidal melanoma, ciliary body melanoma, and iris melanoma. The DecisionDx-UM test was clinically validated on these tumors of the uveal tract. DecisionDx-UM assesses the gene expression profile (GEP) of a subset of genes which are differentially expressed in primary tumor cells compared to cells that have undergone transformation to a metastatic phenotype.
castlebiosciences.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade CSTL
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.